The short version
4 companies supply this market — a reasonable cushion if one runs into trouble.
The numbers behind every sentence are on this page below — and the Watch button emails you when any of them move.
Cyclophosphamide
Cyclophosphamide · CYCLOPHOSPHAMIDE 200 mg/mL · Injection · Intravenous · Nexus Pharmaceuticals, LLC
NDC 14789-0126-05 · 1 VIAL, GLASS in 1 CARTON / 5 mL in 1 VIAL, GLASS · ANDA · View full market →
Medicare Part D
No Medicare Part D plan in CMS's quarterly files lists this product. That usually means it is discontinued, a repackager's listing, or a product no plan has added to its formulary.
How Part D pricing works →NADAC price per unit
No NADAC pricing on file for this NDC — NADAC covers drugs dispensed by retail community pharmacies.
Supply fragility
Not scored — fragility is computed for NADAC-priced NDCs.
Where it's made
- Nexus Pharmaceuticals, LLCUnited Statesanalysis
Establishments this product's FDA label declares, located via FDA registration data. How we built this →
Is this a "specialty" drug?
There's no legal definition — it meets 1 of 6 public criteria. Why that matters →
- Part D specialty tier
- Costs ≥ $950/fill · avg $347.65 per prescription
- Biologic (BLA)
- Injectable / infused
- Orphan-drug exclusivity
- REMS program
Regulatory
- Application
- ANDA216783
- TE code
- AP
- Approval date
- Oct 29, 2024
- Patents / exclusivity
- None on file
Shortage history
No FDA shortage reports for this drug or its presentations.
Recalls (this NDC)
No enforcement reports list this package NDC.
Manufacturers of Cyclophosphamide (Injection)
| Labeler | Strength | First seen | Last seen |
|---|---|---|---|
| Avyxa Pharma, LLC | CYCLOPHOSPHAMIDE 500 mg/mL | Jul 15, 2026 | Sep 3, 2026 |
| Avyxa Pharma, LLC | CYCLOPHOSPHAMIDE 1 g/2mL | Jul 15, 2026 | Sep 3, 2026 |
| Piramal Pharma Solutions Inc. | CYCLOPHOSPHAMIDE ANHYDROUS 200 mg/mL | Jul 15, 2026 | Sep 3, 2026 |
| Eugia US LLC | CYCLOPHOSPHAMIDE 500 mg/2.5mL | Jul 15, 2026 | Sep 2, 2026 |
| Eugia US LLC | CYCLOPHOSPHAMIDE 2 g/10mL | Jul 15, 2026 | Sep 2, 2026 |
| Eugia US LLC | CYCLOPHOSPHAMIDE 1 g/5mL | Jul 15, 2026 | Sep 2, 2026 |
| Nexus Pharmaceuticals, LLC | CYCLOPHOSPHAMIDE 200 mg/mL | Jul 15, 2026 | Aug 31, 2026 |
| Avyxa Pharma, LLC | CYCLOPHOSPHAMIDE 2 g/4mL | Jul 15, 2026 | Aug 28, 2026 |
Roster from daily NDC Directory diffs — first/last seen dates start July 2026.
Cite this page
DrugDashboards, "Cyclophosphamide — NDC 14789-0126-05," retrieved September 3, 2026, https://drugdashboards.com/drug/14789012605.
Free to cite with attribution — see how the data is put together.